Impact of Availability and Use of Coronary Interventions on the Prescription of Aspirin and Lipid Lowering Treatment After Acute Coronary Syndromes

Heart
doi 10.1136/heart.88.1.20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Aspirin and Clopidogrel Hyporesponsiveness Following Acute Coronary Syndromes

Kardiologia Polska
Cardiovascular MedicineCardiology
2018English

Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Acute Coronary Syndromes

British Medical Journal
Medicine
2015English

Acute Coronary Syndromes

2018English

Acute Coronary Syndromes

2007English

Acute Coronary Syndromes

2006English

Acute Coronary Syndromes

JAMA - Journal of the American Medical Association
Medicine
2008English

Current Antithrombotic Therapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions

Interventional Cardiology Review
Cardiovascular MedicineCardiology
2011English

Use of Aspirin, Β-Blockers, and Lipid-Lowering Medications Before Recurrent Acute Myocardial Infarction

Archives of Internal Medicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy